Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic study of freeze-dried Xueshuantong for Injection in healthy volunteers
ChiCTR-ONRC-13003905Phase 4Completed
- Sponsor
- Shanghai Institute of Materia Medica
- Start
- Nov 2013
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Xueshuantong for Injection (6 arms), sponsored by Shanghai Institute of Materia Medica. Primary endpoints: Plasma concentration and Urinary concentration. Started Nov 2013; status: completed.
02
Drugs
Xueshuantong for Injection
Beyond the preview
Go deeper on ChiCTR-ONRC-13003905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-13003905.